Sign in

CIK 0001498382 · Non-accelerated filer<br>Smaller reporting company

TuHURA Biosciences, Inc./NV

Sign in to watch
Ticker
HURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
990360497
Phone
813-875-6600
Business address
10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
Former names
Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
  1. 4 Open-market buy Director bought 50,000 shares at $0.60 ($30,000)
  2. 4 Open-market buy Director bought 16,666 shares at $0.60 ($10,000)
  3. 4 Open-market buy Chief Financial Officer bought 50,000 shares at $0.60 ($30,000)
  4. 4 Open-market buy President, CEO bought 50,000 shares at $0.60 ($30,000)
  5. EFFECT Other Notice of Effectiveness
  6. 424B3 Offering Prospectus
  7. S-1/A Offering Registration Statement
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. S-1/A Offering Registration Statement
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. S-1/A Offering Registration Statement
  15. S-1/A Offering Registration Statement
  16. S-1/A Offering Registration Statement
  17. 8-K Event Results of operations
  18. 10-Q Report Quarterly Report
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 38 of 47 · 929 filings